Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
- 1 April 1998
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 16 (4) , 537-541
- https://doi.org/10.1097/00004872-199816040-00016
Abstract
Haemostatic factors may play a part in the development of acute coronary heart disease. To evaluate as predictors of major coronary events (fatal and non-fatal myocardial infarctions and sudden death) levels of fibrinogen, von Willebrand factor, prothrombin fragment 1+2, thrombin-antithrombin complex, plasminogen activator inhibitor activity and C-reactive protein. We studied 131 men, aged 56-77 years, with treated hypertension and at least one additional cardiovascular risk factor (hypercholesterolaemia, diabetes mellitus or smoking). These patients were recruited from a continuing risk factor intervention study. The mean observation time was 3.0 years. Fourteen patients died and 16 had a major coronary event during the follow-up period. After adjustments for other risk factors, levels of prothrombin fragment 1+2 and C-reactive protein were independent predictors of major coronary events. The other measured haemostatic variables were not significantly associated with major coronary events during follow-up. Fibrinogen and prothrombin fragment 1+2 levels were independent predictors for mortality. Among treated hypertensive men, levels of prothrombin fragment 1+2 and C-reactive protein were independent predictors of major coronary events.Keywords
This publication has 15 references indexed in Scilit:
- Heightened Thrombin Formation but Normal Plasma Levels of Activated Factor VII in Patients With Acute Coronary SyndromesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic diseaseBlood Coagulation & Fibrinolysis, 1994
- The efficacy of multiple risk factor intervention in treated hypertensive men during long‐term follow upJournal of Internal Medicine, 1994
- Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Coagulation system activation and increase of D‐dimer levels in peripheral arterial occlusive diseaseAmerican Journal of Hematology, 1993
- Body weight is more important than family history of hypertension for left ventricular function.Hypertension, 1991
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyJAMA, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Plasminogen activator inhibitor in the blood of patients with coronary artery disease.BMJ, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984